EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

High-Grade Serous Ovarian Carcinoma in the Genomics Era: Current Applications, Challenges and Future Directions

Molly Elizabeth Lewis, Chiara Caricato iD, Hannah Leigh Roberts iD, Subhasheenee Ganesan, Nadia Amel Seksaf iD, Eleni Maniati iD, Michail Sideris iD

International Journal of Molecular Sciences · 06.02.2026 · 27 (3) · 1617

DOI: 10.3390/ijms27031617 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.02.2026. Verfasst von Molly Elizabeth Lewis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AD, UK. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Genomics, Cystadenocarcinoma, Serous. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-grade serous ovarian carcinoma (HGSOC) is characterised by profound genomic instability and limited durable responses to standard therapy, leading to poor prognosis. The use of next-generation sequencing technologies has improved understanding of its molecular landscape, revealing consistent Tumour Protein p53 (TP53) mutations, homologous recombination defects, pathway alterations, and epigenetic dysregulation. Such genomic profiling now underpins the classification criteria between the ovarian cancer subtypes described by the Cancer Genome Atlas. Widespread chromosomal instability and pathogenic variants in multiple genes distinguish HGSOC from other subtypes of ovarian cancer and, further, from low-grade serous ovarian cancer. Importantly, the new-found understanding of the genomic landscape of HGSOC guides the use of platinum-based chemotherapies and Poly(ADP-ribose) Polymerase (PARP) inhibitors, with homologous recombination deficiency emerging as a cancer vulnerability that enhances treatment response. A combined multi-omics approach integrates transcriptomics, proteomics, metabolomics, and epigenomics to further the understanding of the characteristics, therapeutic targets and treatment resistance within HGSOC. Despite these advances, major challenges persist, including intratumoural heterogeneity and the poor diversity of genomic datasets. Artificial Intelligence (AI) technology, Clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing, neoantigen-guided immunotherapy and ovarian cancer vaccination indicate a promising future for genomics-guided interventions and support the integration of genomics within multi-omic approaches to improve HGSOC outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsGenomicsCystadenocarcinoma, SerousHumansFemaleNeoplasm GradingMutation

Stichwörter der Autor:innen

BRCATP53genomicshigh-grade serous ovarian carcinomahomologous recombination

Autor:innen und Institutionen

  • Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AD, UK.
  • Wolfson's Institute of Population Health, Queen Mary University of London, London EC1M 6BQ, UK.
  • Barts Health NHS Foundation Trust, London E14 5HJ, UK.
  • Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.

ORCID-Profile: Chiara Caricato, Hannah Leigh Roberts, Nadia Amel Seksaf, Eleni Maniati, Michail Sideris

Zitieren

APA

Lewis, M. E., Caricato, C., Roberts, H. L., Ganesan, S., Seksaf, N. A., Maniati, E., & Sideris, M. (2026). High-Grade Serous Ovarian Carcinoma in the Genomics Era: Current Applications, Challenges and Future Directions. International Journal of Molecular Sciences, 27(3), 1617. https://doi.org/10.3390/ijms27031617

Vancouver

Lewis ME, Caricato C, Roberts HL, Ganesan S, Seksaf NA, Maniati E, et al. High-Grade Serous Ovarian Carcinoma in the Genomics Era: Current Applications, Challenges and Future Directions. International Journal of Molecular Sciences. 2026;27(3):1617. doi:10.3390/ijms27031617

BibTeX
@article{Lewis2026,
  author = {Lewis, Molly Elizabeth and Caricato, Chiara and Roberts, Hannah Leigh and Ganesan, Subhasheenee and Seksaf, Nadia Amel and Maniati, Eleni and Sideris, Michail},
  title = {High-Grade Serous Ovarian Carcinoma in the Genomics Era: Current Applications, Challenges and Future Directions},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {3},
  pages = {1617},
  doi = {10.3390/ijms27031617}
}
Kostenlos starten →